• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Aaron Lyss on Improving Outcome Measurements in Practices

Video

Very structured processes for vendor selection is necessary to improve outcome measurements and data analytics, explained Aaron Lyss, director of value-based care for Tennessee Oncology.

Very structured processes for vendor selection is necessary to improve outcome measurements and data analytics, explained Aaron Lyss, director of value-based care for Tennessee Oncology.

Transcript (slightly modified)

How can practices get better at measuring outcomes and handling data analytics?

The way that we’ve gone about that is to have very structured processes for how we do vendor selection in areas where we need help. So, for example, our ability to analyze claims data and use claims data for quality improvement has grown incredibly fast over the past 15 or so months that we’ve been in the Oncology Care Model. But, it’s still not where we need it to be.

So, there’s a combination of growing the claims data and analytic capabilities internally as quickly as we can, while contracting for outside help with vendors who can really deliver value in meeting the objectives of reducing unnecessary healthcare costs and enhancing the quality of the patient experience.

Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
ASCO GI 2026 Recap
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Dr Marco del Riccio
Bhavana (Tina) Bhatnagar, DO, West Virginia University Cancer Institute at Wheeling Hospital
Dr Debra Patt
Dr Marco del Riccio
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
© 2026 MJH Life Sciences
AJMC®
All rights reserved.